| Blood oxidative stress markers in Gaucher disease patients. FM Roversi, V D'Almeida, FG Souza, LC Galdieri, BHC Grego, ... Clin Chim Acta 364 (1-2), 316-20, 2006 | 48 | 2006 |
| BRD4 inhibition enhances azacitidine efficacy in acute myeloid leukemia and myelodysplastic syndromes FV Pericole, M Lazarini, LB De Paiva, ASS Duarte, KP Vieira Ferro, ... Frontiers in oncology 9, 16, 2019 | 44 | 2019 |
| Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression FM Roversi, STO Saad, JA Machado-Neto Biomedicine & Pharmacotherapy 101, 278-286, 2018 | 35 | 2018 |
| Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of … FM Roversi, FV Pericole, JA Machado-Neto, ASS Duarte, AL Longhini, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (2), 450-461, 2017 | 31 | 2017 |
| SEMA3A partially reverses VEGF effects through binding to neuropilin-1 B Palodetto, ASS Duarte, MR Lopes, FA Corrocher, FM Roversi, ... Stem cell research 22, 70-78, 2017 | 28 | 2017 |
| WNT5A in tumor development and progression: A comprehensive review MLP Bueno, STO Saad, FM Roversi Biomedicine & Pharmacotherapy 155, 113599, 2022 | 16 | 2022 |
| Hematopoietic cell kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12/CXCR4 axis FM Roversi, MLP Bueno, FV Pericole, STO Saad Frontiers in cell and developmental biology 9, 634044, 2021 | 14 | 2021 |
| Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion FM Roversi, MR Lopes, JA Machado-Neto, ALF Longhini, ASS Duarte, ... Stem cells and development 23 (10), 1109-1120, 2014 | 13 | 2014 |
| Up‐regulation of SPINT 2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion FM Roversi, NM Cury, MR Lopes, KP Ferro, JA Machado‐Neto, ... Journal of Cellular and Molecular Medicine 23 (2), 1562-1571, 2019 | 12 | 2019 |
| Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service MLP BUENO, MB MITESTAINER, JARDA SILVA, BD BENITES, ... Transfus Clin Biol . 28 (3), 258-263, 2021 | 10 | 2021 |
| Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease AF dos Santos, CB Almeida, AF Brugnerotto, FM Roversi, FR Pallis, ... Life sciences 117 (1), 7-12, 2014 | 10 | 2014 |
| Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia FM Roversi, MLP Bueno, JAF da Silva, GR Assis-Mendonça, CO Torello, ... Cancer Immunology, Immunotherapy 71 (8), 1909-1921, 2022 | 7 | 2022 |
| Gene expression analysis of the Brazilian type of hereditary persistence of fetal hemoglobin: identification of genes that could be related to γ-Globin activation FM Roversi, AF da Cunha, AF Brugnerotto, MF Carazzolle, ... Hemoglobin 37 (6), 516-535, 2013 | 6 | 2013 |
| The antitumor effects of WNT5A against hematological malignancies MLP Bueno, STO Saad, FM Roversi Journal of cell communication and signaling 17 (4), 1487-1499, 2023 | 3 | 2023 |
| The-195Câ †’ G Substitution In Brazilian Hereditary Persistence of Fetal Hemoglobin Decreases NF-E1/YY1 Binding and Increases PAX1 Binding to the A Gamma Globin Promoter … FM Roversi, AF Cunha, C Lanaro, AF Brugnerotto, ME Favero, ... Blood 116 (21), 2066, 2010 | 3 | 2010 |
| Methylation of HAI-2/SPINT2 in Bone Marrow Mesenchymal Stromal Cells of MDS and AML Patients Affects Hematopoietic Stem Cell Survival and Adhesion FM Roversi, NM Cury, MR Lopes, FV Pericole, MCA Prax, KP Ferro, ... Blood 126 (23), 2847, 2015 | 2 | 2015 |
| Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents MFL Carvalho, BO de Almeida, MLP Bueno, HP Vicari, K Lima, EM Rego, ... Hematology, Transfusion and Cell Therapy 46 (3), 273-282, 2024 | 1 | 2024 |
| A novel antisense long noncoding RNA modulates NR4A1 protein level in myeloid malignancies FA Corrocher, A Congrains, FS Niemann, B Palodetto, FM Roversi, ... Blood 126 (23), 2442, 2015 | 1 | 2015 |
| Hematopoietic cell kinase (HCK) is involved in myelodysplastic syndromes and acute leukemia pathophysiology by modulating PI3K pathway and enhancing erythroid differentiation FM Roversi, FV Pericole, JA Machado-Neto, AL Longhini, ASS Duarte, ... Blood 124 (21), 1891, 2014 | 1 | 2014 |
| BRD4 short isoform is a myelodysplasia prognostic marker involved in inappropriate DNA damage response FV Pericole, FM Roversi, ASS Duarte, B Palodetto, FA Corrocher, F Traina, ... Blood 124 (21), 3234, 2014 | 1 | 2014 |
Sara Teresinha Olalla SaadProfessora Titular da Disciplina de Hematologia e Hemoterapia, Universidade Estadual de Campinas在 unicamp.br 的电子邮件经过验证
